
A new echocardiography software package released this month analyzes cardiac structure and function pixel by pixel to render detailed functional 3D images that could speed up diagnosis and reduce the number of exams needed in patients undergoing cardiac workups.
GE Healthcare's cSound software, which received 510(k) U.S. Food and Drug Administration (FDA) clearance earlier this year, is being bundled into its Vivid series of advanced ultrasound systems (S70, E90, E95) for marketing in the U.S. and some countries in Europe, Asia, and Latin America, GE said. The first system is already in use at Aurora St. Luke's Medical Center in Milwaukee.
The software works by collecting large amounts of data from the patient's cardiovascular system and selecting precise, pixel-by-pixel information to use in generating images, GE said.
3D view of the mitral valve in motion. Image courtesy of GE Healthcare.Analyzing data in 1 pass
The problem with conventional hardware-based beamforming ultrasound scanners is that they're limited to processing one piece of data at a time, losing some of it in the process and resulting in unclear images, according to the company. In contrast, cSound stores large amounts of channel data, and it does this faster than conventional systems do.
Software-based beamforming identifies the best image data pixel by pixel and then converts the information into meaningful images of the heart. In conventional hardware-based beamforming, this is performed segment by segment and filled in layer by layer to eventually form an advanced image, GE said. However, in software-based beamforming, the software analyzes all of the data at the start of the process, producing a single, high-quality image.
How does the software determine the "best" data from the echo signal using all of the image data? It's based on a specific algorithm, adaptive contrast enhancement (ACE), which determines the quality of the channel data contributing to each pixel of the image, according to Erik Steen, GE's principal engineer for cardiovascular ultrasound.
"This is a large number of data samples, typically in the thousands," Steen wrote in an email to AuntMinnie.com.
ACE is based on statistical analysis of these data, and it works by estimating the likelihood of the data originating from real tissue versus clutter or image noise. It works equally well with normal and abnormal heart anatomy, he said.
Another cSound feature is a volume-rendering algorithm known as HDlive, which combines several methods to render the heart in real-time from echo data, according to Steen. Volume-rendering algorithms treat volume data as a set of semitransparent voxels. Surfaces are then defined implicitly by robust volume gradient calculations.
"Depth coloring, shadowing, and light reflections are combined to provide detailed and realistic-looking images with enhanced depth perception," Steen said.
HDlive doesn't rely on atlases or templates of any kind, but it does benefit from the improved volume image quality provided by cSound, he added.
The GE promotional video below shows software-rendered images of the heart in motion.
Transthoracic or transesophageal echo
In cardiac patients, cSound can be used transesophageally or transthoracically, depending on the application, according to Al Lojewski, GE's general manager of cardiovascular ultrasound.
"They'll typically be doing transesophageal during an intervention, repairing or replacing a valve; they'll also do that for extremely difficult patients," such as obese heart patients, Lojewski said in an interview with AuntMinnie.com.
However echocardiography is performed, the limitations with conventional echo systems are the same, he said: They simply lack sufficient anatomic and functional detail to make a confident diagnosis.
"It's been published that in 10%, 14%, up to 25% [of cases] we can't see the images because maybe the body size is too big, or we can't get between the ribs of a smaller, elderly lady," Lojewski said. "Or maybe it's difficult to see the valve placement, and it leads to more tests and more expense, or exams that involve radiation. With this technology, we believe that we have significantly reduced the number of patients on whom you can't do an exam."
Given recent advances in detailed visualization of cardiac function, ultrasound has the potential to rapidly transform how patients are cared for over the next decade, especially in cardiovascular care, according to Lojewski.
"We envision a day when all cardiologists can see inside any heart, providing more directed care for each patient," he said.
cSound's price point ranges from about $30,000 for a laptop-sized ultrasound machine up to about $250,000 depending on how the scanner is equipped, Lojewski said.


















![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)
